Public Health Implications of Sickle Cell Trait: A Report of the CDC Meeting

详细信息    查看全文

• 作者：Althea M. Grant ; PhD^a ; ^{agrant@cdc.gov} ; Christopher S. Parker ; PhD^a ; Lanetta B. Jordan ; MD ; MPH^b ; ^c ; Mary M. Hulihan ; MPH^a ; Melissa S. Creary ; MPH^a ; Michele A. Lloyd-Puryear ; MD ; PhD^d ; Jonathan C. Goldsmith ; MD^e ; Hani K. Atrash ; MD ; MPH^a
• 刊名：American Journal of Preventive Medicine
• 出版年：2011
• 出版时间：December, 2011
• 年：2011
• 卷：41
• 期：6_supp_S4
• 页码：S435-S439
• 全文大小：1K

文摘

Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.